Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test
Introduction
The Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test is a specialized diagnostic tool designed to detect the presence of Epstein-Barr Virus (EBV) in tumor tissues. This test plays a critical role in the early diagnosis of EBV-related cancers, allowing for timely and targeted treatment options. Understanding the significance of EBV in oncogenesis is essential for effective cancer management.
What the Test Measures
This test specifically measures the early RNA of the Epstein-Barr Virus within tumor tissues. By identifying the presence of EBV, oncologists can assess the potential for EBV-related malignancies, including lymphomas and nasopharyngeal carcinoma.
Who Should Consider This Test
Individuals who may benefit from the Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test include:
- Patients with symptoms of EBV-related cancers such as unexplained weight loss, fever, or lymphadenopathy.
- Individuals with a known history of EBV infection who are at increased risk for developing malignancies.
- Patients with abnormal findings in imaging studies that may suggest the presence of a tumor.
Benefits of Taking the Test
Taking the Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test offers several benefits:
- Early detection of EBV-related cancers, leading to prompt treatment.
- Informed decision-making for oncologists based on test results.
- Enhanced understanding of tumor biology and patient prognosis.
Understanding Your Results
Results from the Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test will indicate the presence or absence of EBV RNA in the tumor tissue. A positive result may suggest the need for further evaluation and treatment options, while a negative result may help rule out EBV involvement in the malignancy.
Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test | 12,000 KSh | 16,000 KSh |
Sample Submission Instructions
Please submit tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. Ensure to ship at room temperature and provide a copy of the Histopathology report, site of biopsy, and clinical history.
Book Your Test Today!
We have branches across Kenya and offer home sample collection services. To book the Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test, call or WhatsApp us at +254711564616 today!
